Details for New Drug Application (NDA): 077997
✉ Email this page to a colleague
The generic ingredient in CAFFEINE CITRATE is caffeine citrate. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the caffeine citrate profile page.
Summary for 077997
Tradename: | CAFFEINE CITRATE |
Applicant: | Fresenius Kabi Usa |
Ingredient: | caffeine citrate |
Patents: | 0 |
Pharmacology for NDA: 077997
Physiological Effect | Central Nervous System Stimulation |
Medical Subject Heading (MeSH) Categories for 077997
Suppliers and Packaging for NDA: 077997
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CAFFEINE CITRATE | caffeine citrate | SOLUTION;INTRAVENOUS | 077997 | ANDA | Fresenius Kabi USA, LLC | 63323-407 | 63323-407-03 | 1 VIAL in 1 BOX (63323-407-03) / 3 mL in 1 VIAL |
CAFFEINE CITRATE | caffeine citrate | SOLUTION;INTRAVENOUS | 077997 | ANDA | Fresenius Kabi USA, LLC | 63323-407 | 63323-407-04 | 1 VIAL in 1 BOX (63323-407-04) / 3 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | EQ 30MG BASE/3ML (EQ 10MG BASE/ML) | ||||
Approval Date: | Jul 20, 2007 | TE: | AP | RLD: | No |
Complete Access Available with Subscription